Cystic kidney disease
Chapter 17:Congenital malformations and chromosomal abnormalities
ICD-10 Q61 is a used to indicate a diagnosis of cystic kidney disease.
Cystic kidney disease (Q61) encompasses a range of hereditary and acquired conditions characterized by the presence of fluid-filled cysts in the kidneys. This category includes conditions such as autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), and medullary cystic kidney disease. These conditions can lead to significant renal impairment and other systemic complications, making early diagnosis and management crucial for patient outcomes. The clinical significance of Q61 lies in its association with chronic kidney disease (CKD) and end-stage renal disease (ESRD), necessitating careful monitoring and treatment strategies to mitigate progression and manage symptoms effectively.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Q61 includes autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), and medullary cystic kidney disease, among others.
Q61 codes should be used when diagnosing patients with cystic kidney diseases, particularly when these conditions are confirmed through imaging or genetic testing.
Documentation should include clinical findings, imaging results, family history, and any genetic testing results that confirm the diagnosis of cystic kidney disease.
